Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease.
Chatterjee P, Pedrini S, Stoops E, Goozee K, Villemagne VL, Asih PR, Verberk IMW, Dave P, Taddei K, Sohrabi HR, Zetterberg H, Blennow K, Teunissen CE, Vanderstichele HM, Martins RN. Chatterjee P, et al. Among authors: villemagne vl. Transl Psychiatry. 2021 Jan 11;11(1):27. doi: 10.1038/s41398-020-01137-1. Transl Psychiatry. 2021. PMID: 33431793 Free PMC article.
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.
Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager NT, Lenzo N, Martins RN, Maruff P, Masters C, Milner A, Pike K, Rowe C, Savage G, Szoeke C, Taddei K, Villemagne V, Woodward M, Ames D; AIBL Research Group. Ellis KA, et al. Int Psychogeriatr. 2009 Aug;21(4):672-87. doi: 10.1017/S1041610209009405. Epub 2009 May 27. Int Psychogeriatr. 2009. PMID: 19470201 Free article.
Relationship between atrophy and beta-amyloid deposition in Alzheimer disease.
Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ, Salvado O, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Research Group. Chételat G, et al. Among authors: villemagne vl. Ann Neurol. 2010 Mar;67(3):317-24. doi: 10.1002/ana.21955. Ann Neurol. 2010. PMID: 20373343
Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging.
Lui JK, Laws SM, Li QX, Villemagne VL, Ames D, Brown B, Bush AI, De Ruyck K, Dromey J, Ellis KA, Faux NG, Foster J, Fowler C, Gupta V, Hudson P, Laughton K, Masters CL, Pertile K, Rembach A, Rimajova M, Rodrigues M, Rowe CC, Rumble R, Szoeke C, Taddei K, Taddei T, Trounson B, Ward V, Martins RN, AIBL Research Group. Lui JK, et al. Among authors: villemagne vl. J Alzheimers Dis. 2010;20(4):1233-42. doi: 10.3233/JAD-2010-090249. J Alzheimers Dis. 2010. PMID: 20413897
Larger temporal volume in elderly with high versus low beta-amyloid deposition.
Chételat G, Villemagne VL, Pike KE, Baron JC, Bourgeat P, Jones G, Faux NG, Ellis KA, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of Ageing (AIBL) Research Group. Chételat G, et al. Among authors: villemagne vl. Brain. 2010 Nov;133(11):3349-58. doi: 10.1093/brain/awq187. Epub 2010 Aug 25. Brain. 2010. PMID: 20739349
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.
Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, Bourgeat P, Ackermann U, Jones G, Szoeke C, Salvado O, Martins R, O'Keefe G, Mathis CA, Klunk WE, Ames D, Masters CL, Rowe CC. Villemagne VL, et al. Ann Neurol. 2011 Jan;69(1):181-92. doi: 10.1002/ana.22248. Ann Neurol. 2011. PMID: 21280088 Free PMC article.
Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group. Chételat G, et al. Among authors: villemagne vl. Brain. 2011 Mar;134(Pt 3):798-807. doi: 10.1093/brain/awq383. Epub 2011 Feb 9. Brain. 2011. PMID: 21310725
Advances in structural and molecular neuroimaging in Alzheimer's disease.
Ellis KA, Rowe CC, Szoeke CE, Villemagne VL, Ames D, Chételat G, Martins RN, Masters CL, Fripp J, Acosta O, Raniga P, Bourgeat PT, Salvado O. Ellis KA, et al. Among authors: villemagne vl. Med J Aust. 2011 Feb 21;194(4):S20-3. doi: 10.5694/j.1326-5377.2011.tb02938.x. Med J Aust. 2011. PMID: 21401483
Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging.
Gupta VB, Laws SM, Villemagne VL, Ames D, Bush AI, Ellis KA, Lui JK, Masters C, Rowe CC, Szoeke C, Taddei K, Martins RN; AIBL Research Group. Gupta VB, et al. Among authors: villemagne vl. Neurology. 2011 Mar 22;76(12):1091-8. doi: 10.1212/WNL.0b013e318211c352. Neurology. 2011. PMID: 21422459
472 results